Erste Asset Management’s Allogene Therapeutics ALLO Stock Holding History

Erste Asset Management’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$847K	Buy	381,400 +350,000	+1,115%	+$769K	0.01%	464
2026 Q1	$69.7K	Hold	31,400	–	–	﹤0.01%	584
2025 Q4	$43.3K	Hold	31,400	–	–	﹤0.01%	587
2025 Q3	$39.9K	Hold	31,400	–	–	﹤0.01%	602
2025 Q2	$37.1K	Hold	31,400	–	–	﹤0.01%	868
2025 Q1	$48.7K	Hold	31,400	–	–	﹤0.01%	510
2024 Q4	$68.8K	Hold	31,400	–	–	﹤0.01%	510
2024 Q3	$91.4K	Hold	31,400	–	–	﹤0.01%	500
2024 Q2	$76.6K	Hold	31,400	–	–	﹤0.01%	499
2024 Q1	$140K	Hold	31,400	–	–	﹤0.01%	482
2023 Q4	$103K	Hold	31,400	–	–	﹤0.01%	503
2023 Q3	$107K	Hold	31,400	–	–	﹤0.01%	499
2023 Q2	$144K	Hold	31,400	–	–	﹤0.01%	506
2023 Q1	$156K	Hold	31,400	–	–	﹤0.01%	511
2022 Q4	$187K	Hold	31,400	–	–	﹤0.01%	495
2022 Q3	$324K	Hold	31,400	–	–	0.01%	467
2022 Q2	$367K	Hold	31,400	–	–	0.01%	459
2022 Q1	$294K	Sell	31,400 -9,400	-23%	-$97.9K	0.01%	483
2021 Q4	$626K	Hold	40,800	–	–	0.01%	408
2021 Q3	$1.05M	Hold	40,800	–	–	0.02%	336
2021 Q2	$1.03M	Hold	40,800	–	–	0.02%	342
2021 Q1	$1.36M	Hold	40,800	–	–	0.03%	313
2020 Q4	$1.1M	Hold	40,800	–	–	0.03%	325
2020 Q3	$1.54M	Hold	40,800	–	–	0.05%	274
2020 Q2	$1.71M	Hold	40,800	–	–	0.07%	247
2020 Q1	$819K	Buy	+40,800	New	+$972K	0.05%	276

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Erste Asset Management's ALLO Position: Q2 2026 in Review

Erste Asset Management increased its Allogene Therapeutics (ALLO) stake by 1,115% in Q2 2026, buying an estimated $769K and bringing the position to 381,400 shares worth $847K. The position accounts for 0.01% of the portfolio, ranked #464.

Erste Asset Management first reported a position in ALLO in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.71M in Q2 2020. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

Erste Asset Management held 381,400 shares of Allogene Therapeutics worth $847K as of Q2 2026.
Erste Asset Management bought 350,000 Allogene Therapeutics shares in Q2 2026, an estimated $769K.
Allogene Therapeutics made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #464 holding.
Erste Asset Management first reported a position in Allogene Therapeutics in Q1 2020 and has held it in 26 quarters since.
Erste Asset Management's Allogene Therapeutics position peaked at $1.71M in Q2 2020.
209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.